Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Disease Infection”

12,309 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 12,309 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Post-approval studies (Phase 4)Active Not RecruitingNCT04032860
What this trial is testing

RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection

Who this might be right for
HCCHBV Coinfection
West China Hospital 104
Early research (Phase 1)Ended earlyNCT02289482
What this trial is testing

A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 20
Not applicableStudy completedNCT02630082
What this trial is testing

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru

Who this might be right for
HIV InfectionsAcquired Immunodeficiency SyndromeLentivirus Infections+8 more
National Institute of Allergy and Infectious Diseases (NIAID) 29
Early research (Phase 1)WithdrawnNCT06533280
What this trial is testing

VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)

Who this might be right for
HIV Infections
ViiV Healthcare
Not applicableStudy completedNCT02953080
What this trial is testing

Improving Outcomes in HIV Patients Using Mobile Phone Based Interactive Software Support

Who this might be right for
Human Immunodeficiency Virus
Makerere University 600
Post-approval studies (Phase 4)Study completedNCT00338780
What this trial is testing

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong
Early research (Phase 1)Not Yet RecruitingNCT07113496
What this trial is testing

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Who this might be right for
Relapsed or Refractory B-cell Hematologic MalignanciesB-cell Acute Lymphoblastic Leukemia (B-ALL)Multiple Myeloma (MM)+3 more
The First Affiliated Hospital with Nanjing Medical University 27
Testing effectiveness (Phase 2)Study completedNCT00433069
What this trial is testing

Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

Who this might be right for
Chronic Hepatitis C
University Hospital, Geneva 5
Post-approval studies (Phase 4)Ended earlyNCT02429583
What this trial is testing

Effects of Persistent Innate Immune Activation on Vaccine Efficacy

Who this might be right for
Hepatitis C Infection
Rockefeller University 24
Testing effectiveness (Phase 2)UnknownNCT06282783
What this trial is testing

Studying Topiramate for Re-Activating the HIV-1 Reservoir

Who this might be right for
HIV-1-infectionHivHIV Infections+1 more
Erasmus Medical Center 12
Not applicableWithdrawnNCT01691235
What this trial is testing

SIMpill Medication Dispensing Device in the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT01935635
What this trial is testing

A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 400
Testing effectiveness (Phase 2)Ended earlyNCT02759315
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Not applicableStudy completedNCT00026676
What this trial is testing

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 82
Testing effectiveness (Phase 2)Study completedNCT01171989
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 391
Not applicableEnrolling By InvitationNCT06183723
What this trial is testing

Optimizing Care for Challenging People Living With HIV

Who this might be right for
Adherence, MedicationHIV InfectionsSocial Media
Kaohsiung Medical University Chung-Ho Memorial Hospital 210
Post-approval studies (Phase 4)WithdrawnNCT02969746
What this trial is testing

Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants

Who this might be right for
Anticoagulants; Circulating, Hemorrhagic Disorder
University Hospital, Angers
Post-approval studies (Phase 4)UnknownNCT04738955
What this trial is testing

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

Who this might be right for
Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
Shandong Provincial Hospital 230
Not applicableUnknownNCT05699785
What this trial is testing

Comparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Therapy With Second-generation Anti-integrase Drugs on Triple Versus Dual Therapy

Who this might be right for
Hiv
Centre Hospitalier Universitaire de Nice 500
Load More Results